Given that a decrease in the level of BDNF and other neurotrophic factors have been observed in the postmortem brain tissue and serum from PD patients and in animal models of PD36–39, we surmised that the level of BDNF in PBMCs will be decreased as well, which would be consistent with PD pathology. This evidence concerns the gene BDNF and Parkinson disease.